APA (7th ed.) Citation

Apolónio, J. D., Dias, J. S., Fernandes, M. T., Komosa, M., Lipman, T., Zhang, C. H., . . . Castelo-Branco, P. (2022). THOR is a targetable epigenetic biomarker with clinical implications in breast cancer. Clinical Epigenetics, 14(1), 1. https://doi.org/10.1186/s13148-022-01396-3

Chicago Style (17th ed.) Citation

Apolónio, Joana Dias, et al. "THOR Is a Targetable Epigenetic Biomarker with Clinical Implications in Breast Cancer." Clinical Epigenetics 14, no. 1 (2022): 1. https://doi.org/10.1186/s13148-022-01396-3.

MLA (9th ed.) Citation

Apolónio, Joana Dias, et al. "THOR Is a Targetable Epigenetic Biomarker with Clinical Implications in Breast Cancer." Clinical Epigenetics, vol. 14, no. 1, 2022, p. 1, https://doi.org/10.1186/s13148-022-01396-3.